✦ LIBER ✦

Randomized comparison of Zotarolimus-Eluting Endeavor Sprint versus bare-metal stent implantation in uncertain drug-eluting stent candidates: Rationale, design, and characterization of the patient population for the Zotarolimus-eluting Endeavor Sprint stent in Uncertain DES Candidates study

✍ Scribed by Valgimigli, Marco; Patialiakas, Athanasios; Thury, Attila; Colangelo, Salvatore; Campo, Gianluca; Tebaldi, Matteo; Ungi, Imre; Tondi, Stefano; Roffi, Marco; Menozzi, Alberto; de Cesare, Nicoletta; Garbo, Roberto; Meliga, Emanuele; Testa, Luca; Gabriel, Henrique M.; Airoldi, Flavio; Ferlini, Marco; Liistro, Francesco; Dellavalle, Antonio; Vranckx, Pascal; Briguori, Carlo

Book ID: 125447570
Publisher: Elsevier Science
Year: 2013
Tongue: English
Weight: 518 KB
Volume: 166
Category: Article
ISSN: 1097-6744
DOI: 10.1016/j.ahj.2013.07.033

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Rationale and design of the Patient Rela

Rationale and design of the Patient Related OuTcomes with Endeavor versus Cypher stenting Trial (PROTECT): Randomized controlled trial comparing the incidence of stent thrombosis and clinical events after sirolimus or zotarolimus drug-eluting stent implantation

✍ Edoardo Camenzind; William Wijns; Laura Mauri; Eric Boersma; Keyur Parikh; Volkh 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 347 KB

A 2 × 2 Factorial Design Rando

A 2 × 2 Factorial Design Randomised Control Trial Assessing the Efficacy of High Pressure Coronary Stent Deployment and Post-dilation to Achieve Relative Oversize Compared to Nominal Stent Deployment and Sizing in Patients at High Risk for Re-stenosis Using the Endeavor Drug-eluting Stent Versus Bare Metal Stents: The HEADROOM trial—Report of the First 100 Patients

✍ Joseph Matthews; Mark Pitney; Nigel Jepson; Robert Giles; Daniel Friedman; Roger 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 84 KB

Two-by-two factorial comparison of high-

Two-by-two factorial comparison of high-bolus-dose tirofiban followed by standard infusion versus abciximab and sirolimus-eluting versus bare-metal stent implantation in patients with acute myocardial infarction: Design and rationale for the MULTI-STRATEGY trial

✍ Marco Valgimigli; Leonardo Bolognese; Maurizio Anselmi; Gianluca Campo; Alfredo 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 164 KB

Rationale and design of the dual antipla

Rationale and design of the dual antiplatelet therapy study, a prospective, multicenter, randomized, double-blind trial to assess the effectiveness and safety of 12 versus 30 months of dual antiplatelet therapy in subjects undergoing percutaneous coronary intervention with either drug-eluting stent or bare metal stent placement for the treatment of coronary artery lesions

✍ Laura Mauri; Dean J. Kereiakes; Sharon-Lise T. Normand; Stephen D. Wiviott; Davi 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 307 KB